Search the Newsreel

Arteris Inc (AIP) Earnings Forecast: Future EPS & Revenue Growth Estimates

Ameris Bancorp (ABCB) Stock Forecasts

Argus has raised its target price for Ameris Bancorp (ABCB) to $99.00. The company operates as a bank holding company through its subsidiary, Ameris Bank, with branches across Georgia, Alabama, Florida, and South Carolina. The current stock price for ABCB is $87.73.

Behavioral Patterns of AMSF and Institutional Flows

This article analyzes Amerisafe Inc. (NASDAQ: AMSF) using AI models to identify behavioral patterns and institutional flows. It suggests a near-term neutral sentiment, potentially pausing mid and long-term weakness, and highlights an exceptional short setup with a 30.1:1 risk-reward ratio. The analysis provides specific …

Precision Trading with Ameris Bancorp (ABCB) Risk Zones

This article provides a precision trading analysis for Ameris Bancorp (ABCB), indicating divergent sentiment across all time horizons and suggesting choppy conditions. It highlights an exceptional 18.3:1 risk-reward short setup and outlines three institutional trading strategies tailored for different risk profiles: Position Trading, Momentum …

Did STERIS’ (STE) Record Chemistries Bet and Dividend Hike Just Recast Its Earnings Narrative?

STERIS plc (STE) recently reported strong Q1 fiscal 2027 results, including increased sales and earnings, a reaffirmed full-year outlook, and its 21st consecutive annual dividend increase. The company also announced a significant US$600 million investment in a new chemistries Center of Excellence in North …

Verisk Analytics, Inc. (VRSK) Stock Forecasts

This article provides a stock forecast for Verisk Analytics, Inc. (VRSK), a data and analytics provider for property-casualty insurers. It highlights that Verisk's earnings were mostly steady in the second quarter and includes a summary of the company's background. The report also lists related …

Anteris Technologies Global Corp (ASX: AVR) Share Price Update: Stock Rises After Market Close as Health Care Index Ends Lower

Anteris Technologies Global Corp (ASX: AVR) saw its shares increase by approximately 5.19% to close at $11.55 on August 7, 2026, with a trading volume of 14,907 shares and a market capitalization of $174.72 million. This rise occurred despite the broader S&P/ASX 200 Health …

Xeris Biopharma Holdings Inc (XERS) Stock News Today

This article provides current stock information for Xeris Biopharma Holdings Inc (XERS) including its recent closing price, market capitalization, and P/E ratio. It highlights that the company's stock experienced a gain of 7.74% and indicates that more news and earnings updates are expected soon …

Arteris, Inc. Stock 12‑Month Price Target Raised to $41, Implies 30% Upside

The average 12-month price target for Arteris, Inc. (AIP) stock has been raised from $39.33 to $41 by 6 analysts, with forecasts ranging from $38 to $50 per share. This new target suggests a potential upside of approximately 30% from the Aug. 6 closing …

Ameris Bancorp (ABCB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Ameris Bancorp (ABCB), detailing its current earnings forecast score, average price target from analysts, and a peer comparison within the Banking Services industry. It also includes expected revenue and EPS for upcoming quarters, as well as an …

Delaware judge orders Verisk to proceed with $2.35 billion AccuLynx deal By Reuters

A Delaware judge has ordered Verisk to complete its planned $2.35 billion acquisition of AccuLynx, seven months after Verisk attempted to terminate the deal. The judge found Verisk's termination invalid, stating its "willful conduct caused the failure of a condition to closing." The acquisition, …

Should Xeris Biopharma Holdings (XERS) Be Revalued After Strong Q2 Revenue And Fresh Guidance?

Xeris Biopharma Holdings (XERS) is attracting investor attention following its Q2 earnings report, which included strong performance and a refined full-year 2026 revenue outlook. The stock is currently trading at $7.93, with a recent 7.74% one-day return, and analysts consider it undervalued with a …

UBS Maintains Steris PLC(STE.US) With Buy Rating, Cuts Target Price to $270

UBS has reiterated its Buy rating for Steris PLC (STE.US) but has reduced the target price for the company's stock to $270. This adjustment reflects a continued positive outlook on Steris PLC despite a revised valuation.

VeriSign, Inc. $VRSN Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. reduced its stake in VeriSign, Inc. (NASDAQ:VRSN) by 36.0% in the second quarter, selling 174,207 shares and now owning 310,344 shares valued at $78.07 million. Despite this, other institutional investors have recently increased their holdings. VeriSign reported strong quarterly earnings, …

Arteris (AIP) Stock Revenue Growth Collides With Widening Losses

Arteris (AIP) reported strong Q2 2026 revenue of US$24.1 million, driven by record annual contract value and royalties, indicating solid demand for its chip networking IP, particularly from AI and data center sectors. However, investor sentiment was negative due to widening losses, with net …

Delaware court blocks Verisk’s exit from $2.35 billion AccuLynx deal

Investing.com -- A Delaware judge has ordered Verisk Analytics to attempt to complete its proposed $2.35 billion acquisition of roofing software provider AccuLynx, Reuters reported on Friday, more than seven months after Verisk terminated the transaction. Delaware Chancery Court Judge Bonnie David ruled that …

Anteris Technologies Global Corp (AVR) Stock News Today

This article provides current stock information for Anteris Technologies Global Corp (AVR), including its stock price, market capitalization, and a note about upcoming news. As of the close on August 7th, the stock was trading at $8.910, up 6.58%. The article indicates that more …

VeriSign, Inc (VRSN) Stock News Today

This article from TradingKey provides current stock information for VeriSign, Inc (VRSN), including its real-time price, market capitalization, and P/E ratio. It indicates that more news, earnings reports, and analyst ratings for VRSN will be available soon. The page serves as a hub for …

STERIS plc (Ireland) (STE) Stock Forecasts

STERIS plc (STE) is a medical technology company specializing in sterilization services and infection prevention, holding a leading position in contract sterilization. A recent Morningstar report highlights the company's healthy fundamentals, which are enabling accelerated share repurchases and increased investment. The report provides a …

Is Aeris Resources (ASX:AIS) Rewriting Its Growth Story With Higher 2027 Capital And Exploration Spend?

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Anteris Technologies Global (AVR) Projected to Announce Earnings on Friday

Anteris Technologies Global (AVR) is projected to announce its Q2 2026 earnings before the market opens on Friday, August 14th, with analysts expecting a loss of $0.2073 per share and revenue of $1.50 million. The company missed estimates in its previous quarter and currently …

VeriSign, Inc (VRSN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for VeriSign, Inc (VRSN), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 6 analysts, the stock has an average "Buy" trend with a target price of $297.50, and the company's expected revenue …

Xeris Biopharma (XERS) Stock Jumps On Record Revenue Despite Wider Losses

Jefferies upgrades Arteris stock rating on profitability outlook

Jefferies has upgraded Arteris Inc. (NASDAQ:AIP) stock rating from Hold to Buy and increased its price target to $50.00, citing increased comfort with the company's path to non-GAAP profitability. The firm expects Arteris to achieve profitability by Q4 2026, driven by an 88% gross …

Needham Maintains Steris PLC(STE.US) With Hold Rating

Needham has reiterated its Hold rating on Steris PLC (STE.US). This indicates that the analyst firm is advising investors to maintain their current position in the stock without buying or selling.

Steris PLC stock outperforms competitors on strong trading day

Shares of Steris PLC (STE) rose 2.45% on Friday to $237.47, outperforming the broader market which also saw gains with the S&P 500 Index up 0.62% and the Dow Jones Industrial Average rising 0.28%. This strong performance ended a two-day losing streak for the …

STERIS plc 2026: Revenue $1.49B, EPS $2.04— 10-Q Summary

STERIS plc (STE) reported its 2026 quarterly results with revenue of $1.49 billion and diluted EPS of $2.04, marking significant year-over-year growth in both metrics. The revenue increase of 7.3% was driven by higher volume and pricing, especially in Healthcare and Life Sciences, with …

STERIS plc (NYSE: STE) lifts Q1 2027 revenue to $1.49B, EPS hits $2.04

Ameris Bancorp Q2 FY26 net income drops 53.19% to $51.4 million; net interest margin widens 11 basis points to 3.88%

Ameris Bancorp reported a significant drop in Q2 FY26 net income to $51.4 million, a 53.19% decrease, primarily due to an $82.5 million litigation expense accrual. Despite this, the company saw an 8.89% increase in tax-equivalent net interest income and an 11 basis point …

Ameris Bancorp Q2 2026: Revenue $365.6M, Net income $51.4M, EPS $0.77— 10-Q Summary

Ameris Bancorp reported its second-quarter 2026 results, showing total revenue of $365.6 million and diluted EPS of $0.77. The net income attributable to common shareholders was $51.4 million, a decrease from the prior year's second quarter. The report highlighted a 5.1% year-over-year revenue increase …

UBS Adjusts Price Target on STERIS to $270 From $275, Maintains Buy Rating

UBS has adjusted its price target for STERIS (NYSE: STE) to $270, down from $275, while reaffirming a Buy rating on the stock. This revision comes as analysts reassess the company's valuation. Despite the slight reduction in the price target, UBS continues to recommend …

Arteris (AIP) Grew Revenue And Named A New CFO, Is It Still Undervalued?

Amerisafe Inc (AMSF) Earnings Forecast: Future EPS & Revenue Growth Estimates

Verisk Analytics Inc. stock outperforms competitors on strong trading day

Verisk Analytics Inc. (VRSK) saw its stock increase by 1.09% to $191.82 on Friday, marking its second consecutive day of gains. This performance outpaced the broader market, with the S&P 500 Index rising 0.62% and the Dow Jones Industrial Average rising 0.28% on the …

Narrow-Moat Steris' Recurring Revenue and Margin Improvement Create Opportunistic Outlook

Steris, a narrow-moat company, is a leading provider of sterilization products and services in healthcare. Recent acquisitions have expanded its portfolio, positioning it as a "one-stop shop" for outpatient settings. The company's focus on recurring revenue and margin improvements suggests an opportunistic outlook, further …